Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST). (Q46478452)
Jump to navigation
Jump to search
scientific article published in May 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST). |
scientific article published in May 2005 |
Statements
1 reference
Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST). (English)
1 reference
Mihai Gheorghiade
1 reference
Liliana Grinfeld
1 reference
Faiez Zannad
1 reference
Karl Swedberg
1 reference
James E Udelson
1 reference
Christopher Zimmer
1 reference
Cesare Orlandi
1 reference
John C Burnett
1 reference
David Demets
1 reference
Aldo Maggioni
1 reference
Marvin A Konstam
1 reference
1 May 2005
1 reference
11
1 reference
4
1 reference
260-269
1 reference